Effects of Late Administration of Pentoxifylline and Tocotrienols in an Image-Guided Rat Model of Localized Heart Irradiation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Sridharan, Vijayalakshmi ^a   Tripathi, Preeti ^a   Sharma, Sunil ^b   Corry, Peter M ^b   Moros, Eduardo G ^c   Singh, Awantika ^a   Compadre, Cesar M ^a   Hauer Jensen, Martin ^a,d   Boerma, Marjan ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; MITOGEN ACTIVATED PROTEIN KINASE 1; NEU DIFFERENTIATION FACTOR; PENTOXIFYLLINE; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; THROMBOPLASTIN; TOCOMIN SUPRABIO; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFICACY; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE FIBROSIS; MACROPHAGE; MALE; MAST CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION INDUCED HEART DISEASE; RAT; X IRRADIATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL COUNT; DRUG INTERACTIONS; ENDOTHELIAL CELLS; HEART; HEART VENTRICLES; MALE; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, ANIMAL; ORGANS AT RISK; PENTOXIFYLLINE; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-AKT; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY, IMAGE-GUIDED; RATS; RATS, SPRAGUE-DAWLEY; TOCOTRIENOLS;

EID: 84880678458     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068762     Document Type: Article

References (56)

1. Early Breast Cancer Trialists Collaborative Group (2000) Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355: 1757-1770. doi:10.1016/S0140-6736(00)02263-7. PubMed: 10832826.
2. Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, et al. (2011) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117: 412-418. doi:10.1182/blood-2010-06-291328. PubMed: 20858859.
3. Heidenreich PA, Kapoor JR, (2009) Radiation induced heart disease: systemic disorders in heart disease. Heart 95: 252-258. PubMed: 19144884.
4. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, et al. (2009) Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 75: 1173-1180. doi:10.1016/j.ijrobp.2008.12.048. PubMed: 19386423.
5. Kole TP, Aghayere O, Kwah J, Yorke ED, Goodman KA, (2012) Comparison of Heart and Coronary Artery Doses Associated with Intensity-Modulated Radiotherapy Versus Three-Dimensional Conformal Radiotherapy for Distal Esophageal Cancer. Int J Radiat Oncol Biol Phys 83: 1580-1586. doi:10.1016/j.ijrobp.2011.10.053. PubMed: 22284687.
6. Wu WC, Chan CL, Wong YW, Cuijpers JP, (2009) A study on the influence of breathing phases in intensity-modulated radiotherapy of lung tumours using four-dimensional CT. Br J Radiol 83: 252-256. PubMed: 19723769.
7. Verstegen NE, Lagerwaard FJ, Senan S, (2012) Developments in early-stage NSCLC: advances in radiotherapy. Ann Oncol 23 (Suppl 10):: x46-x51. doi:10.1093/annonc/mds301. PubMed: 22987992.
8. Schubotz R, Muhlfellner O, (1977) The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane. Curr Med Res Opin 4: 609-617. doi:10.1185/03007997709115279. PubMed: 590022.
9. Rube CE, Wilfert F, Uthe D, Schmid KW, Knoop R, et al. (2002) Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. Radiother Oncol 64: 177-187. doi:10.1016/S0167-8140(02)82878-X. PubMed: 12242128.
10. Fang CC, Lai MN, Chien CT, Hung KY, Tsai CC, et al. (2003) Effects of pentoxifylline on peritoneal fibroblasts and silica-induced peritoneal fibrosis. Perit Dial Int 23: 228-236. PubMed: 12938822.
11. Seigneur M, Dufourcq P, Belloc F, Lenoble M, Renard M, et al. (1995) Influence of pentoxifylline on membrane thrombomodulin levels in endothelial cells submitted to hypoxic conditions. J Cardiovasc Pharmacol 25 Suppl 2: S85-S87.
12. Ohdama S, Takano S, Ohashi K, Miyake S, Aoki N, (1991) Pentoxifylline prevents tumor necrosis factor-induced suppression of endothelial cell surface thrombomodulin. Thromb Res 62: 745-755. doi:10.1016/0049-3848(91)90378-A. PubMed: 1656544.
13. Ozturk B, Egehan I, Atavci S, Kitapci M, (2004) Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int J Radiat Oncol Biol Phys 58: 213-219. doi:10.1016/S0360-3016(03)01444-5. PubMed: 14697441.
14. Hille A, Christiansen H, Pradier O, Hermann RM, Siekmeyer B, et al. (2005) Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181: 606-614. doi:10.1007/s00066-005-1390-y. PubMed: 16170489.
15. Delanian S, Balla-Mekias S, Lefaix JL, (1999) Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 17: 3283-3290. PubMed: 10506631.
16. Boerma M, Roberto KA, Hauer-Jensen M, (2008) Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiat Oncol Biol Phys 72: 170-177. doi:10.1016/j.ijrobp.2008.06.721. PubMed: 18632215.
17. Liu H, Xiong M, Xia YF, Cui NJ, Lu RB, et al. (2009) Studies on pentoxifylline and tocopherol combination for radiation-induced heart disease in rats. Int J Radiat Oncol Biol Phys 73: 1552-1559. doi:10.1016/j.ijrobp.2008.12.005. PubMed: 19306752.
18. Berbee M, Fu Q, Boerma M, Wang J, Kumar KS, et al. (2009) gamma-Tocotrienol ameliorates intestinal radiation injury and reduces vascular oxidative stress after total-body irradiation by an HMG-CoA reductase-dependent mechanism. Radiat Res 171: 596-605. doi:10.1667/RR1632.1. PubMed: 19580495.
19. Satyamitra MM, Kulkarni S, Ghosh SP, Mullaney CP, Condliffe D, et al. (2011) Hematopoietic recovery and amelioration of radiation-induced lethality by the vitamin E isoform delta-tocotrienol. Radiat Res 175: 736-745. doi:10.1667/RR2460.1. PubMed: 21434782.
20. Naito Y, Shimozawa M, Kuroda M, Nakabe N, Manabe H, et al. (2005) Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180: 19-25. doi:10.1016/j.atherosclerosis.2004.11.017. PubMed: 15823271.
21. Berbee M, Fu Q, Boerma M, Sree KK, Loose DS, et al. (2012) Mechanisms underlying the radioprotective properties of gamma-tocotrienol: comparative gene expression profiling in tocol-treated endothelial cells. Genes Nutr 7: 75-81. doi:10.1007/s12263-011-0228-8. PubMed: 21516479.
22. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ, (1993) Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 268: 11230-11238. PubMed: 8388388.
23. Song BL, Bose-Boyd RA, (2006) Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem 281: 25054-25061. doi:10.1074/jbc.M605575200. PubMed: 16831864.
24. Berbee M, Fu Q, Garg S, Kulkarni S, Kumar KS, et al. (2011) Pentoxifylline enhances the radioprotective properties of gamma-tocotrienol: differential effects on the hematopoietic, gastrointestinal and vascular systems. Radiat Res 175: 297-306. doi:10.1667/RR2399.1. PubMed: 21388273.
25. National Research Council (2011) Guide for the Care and Use of Laboratory Animals. Washington: The National Academies Press. 220pp.
26. Sharma S, Moros EG, Boerma M, Sridharan V, Han EY, et al. (2013) A novel technique for image-guided local heart irradiation in the rat. Technol Cancer Res Treat 1: 47-57.
27. Ma CM, Coffey CW, DeWerd LA, Liu C, Nath R, et al. (2001) AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology. Med Phys 28: 868-893. doi:10.1118/1.1374247. PubMed: 11439485.
28. Devic S, Seuntjens J, Sham E, Podgorsak EB, Schmidtlein CR, et al. (2005) Precise radiochromic film dosimetry using a flat-bed document scanner. Med Phys 32: 2245-2253. doi:10.1118/1.1929253. PubMed: 16121579.
29. Sridharan V, Tripathi P, Sharma SK, Moros EG, Corry P, et al. (2012) Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system. Cancer Res 72: 4984-4992. doi:10.1158/0008-5472.CAN-12-1831. PubMed: 22865451.
30. Boerma M, Wang J, Wondergem J, Joseph J, Qiu X, et al. (2005) Influence of mast cells on structural and functional manifestations of radiation-induced heart disease. Cancer Res 65: 3100-3107. PubMed: 15833839.
31. Malerba M, Ragnoli B, Salameh M, Sennino G, Sorlini ML, et al. (2011) Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease. J Biol Regul Homeost Agents 25: 443-451. PubMed: 22023769.
32. Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, et al. (2012) Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 84: e639-e646. doi:10.1016/j.ijrobp.2012.07.1708. PubMed: 22975617.
33. Leroy J, Richter W, Mika D, Castro LR, Abi-Gerges A, et al. (2011) Phosphodiesterase 4B in the cardiac L-type Ca(2) channel complex regulates Ca(2) current and protects against ventricular arrhythmias in mice. J Clin Invest 121: 2651-2661. doi:10.1172/JCI44747. PubMed: 21670503.
34. Ravens U, Himmel HM, Fluss M, Davia K, Harding SE, (1996) Phosphodiesterase inhibition and Ca2+ sensitization. Mol Cell Biochem 157: 245-249. PubMed: 8739254.
35. Khosla P, Patel V, Whinter JM, Khanna S, Rakhkovskaya M, et al. (2006) Postprandial levels of the natural vitamin E tocotrienol in human circulation. Antioxid Redox Signal 8: 1059-1068. doi:10.1089/ars.2006.8.1059. PubMed: 16771695.
36. Hopewell JW, (1980) The importance of vascular damage in the development of late radiation effects in normal tissues. In: Meyn RE, Withers HR, eds. Radiation Biology in Cancer Research pp. 449-459.
37. Wang J, Boerma M, Fu Q, Hauer-Jensen M, (2007) Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J Gastroenterol 13: 3047-3055. PubMed: 17589919.
38. Boerma M, Kruse JJ, van Loenen M, Klein HR, Bart CI, et al. (2004) Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation. Strahlenther Onkol 180: 109-116. doi:10.1007/s00066-004-1138-0.
39. Seemann I, Gabriels K, Visser NL, Hoving S, te Poele JA, et al. (2012) Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol 103: 143-150. doi:10.1016/S0167-8140(12)72321-6. PubMed: 22112779.
40. Coe DA, Freischlag JA, Johnson D, Mudaliar JH, Kosciesza SA, et al. (1997) Pentoxifylline prevents endothelial damage due to ischemia and reperfusion injury. J Surg Res 67: 21-25. doi:10.1006/jsre.1996.4940. PubMed: 9070176.
41. Berbee M, Fu Q, Boerma M, Pathak R, Zhou D, et al. (2011) Reduction of radiation-induced vascular nitrosative stress by the vitamin E analog gamma-tocotrienol: evidence of a role for tetrahydrobiopterin. Int J Radiat Oncol Biol Phys 79: 884-891. doi:10.1016/j.ijrobp.2010.08.032. PubMed: 20950957.
42. Lemmens K, Fransen P, Sys SU, Brutsaert DL, De Keulenaer GW, (2004) Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase. Circulation 109: 324-326. doi:10.1161/01.CIR.0000114521.88547.5E. PubMed: 14732742.
43. Liu X, Gu X, Li Z, Li X, Li H, et al. (2006) Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 48: 1438-1447. doi:10.1016/j.jacc.2006.05.057. PubMed: 17010808.
44. Bian Y, Sun M, Silver M, Ho KK, Marchionni MA, et al. (2009) Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Am J Physiol Heart Circ Physiol 297: H1974-H1983. doi:10.1152/ajpheart.01010.2008. PubMed: 19801490.
45. Sridharan V, Sharma SK, Moros EG, Corry PM, Tripathi P, Lieblong BJ, Guha C, Hauer-Jensen M, Boerma M, (2013) Effects of radiation on the epidermal growth factor receptor pathway in the heart. Int J Radiat Biol (in press).
46. Conway EM, (2012) Thrombomodulin and its role in inflammation. Semin Immunopathol 34: 107-125. doi:10.1007/s00281-011-0282-8. PubMed: 21805323.
47. Koutsi A, Papapanagiotou A, Papavassiliou AG, (2008) Thrombomodulin: from haemostasis to inflammation and tumourigenesis. Int J Biochem Cell Biol 40: 1669-1673. doi:10.1016/j.biocel.2007.06.024. PubMed: 17709273.
48. Wang J, Zheng H, Ou X, Fink LM, Hauer-Jensen M, (2002) Deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis. Am J Pathol 160: 2063-2072. doi:10.1016/S0002-9440(10)61156-X. PubMed: 12057911.
49. Verheij M, Dewit LG, Van Mourik JA, (1995) The effect of ionizing radiation on endothelial tissue factor activity and its cellular localization. Thromb Heamost 73: 894-895.
50. Fajardo LF, Stewart JR, (1973) Pathogenesis of radiation-induced myocardial fibrosis. Lab Invest 29: 244-257. PubMed: 4724850.
51. Moriwaki H, Stempien-Otero A, Kremen M, Cozen AE, Dichek DA, (2004) Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ Res 95: 637-644. doi:10.1161/01.RES.0000141427.61023.f4. PubMed: 15297377.
52. Zingg JM, (2007) Vitamin E and mast cells. Vitam Horm 76: 393-418. doi:10.1016/S0083-6729(07)76015-6. PubMed: 17628183.
53. Rose BA, Force T, Wang Y, (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90: 1507-1546. doi:10.1152/physrev.00054.2009. PubMed: 20959622.
54. Sbroggio M, Carnevale D, Bertero A, Cifelli G, De BE, et al. (2011) IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload. Cardiovasc Res 91: 456-464. doi:10.1093/cvr/cvr103. PubMed: 21493702.
55. Li XM, Ma YT, Yang YN, Liu F, Chen BD, et al. (2009) Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Clin Exp Pharmacol Physiol 36: 1054-1061. doi:10.1111/j.1440-1681.2009.05243.x. PubMed: 19566828.
56. Liu Q, Molkentin JD, (2011) Protein kinase Calpha as a heart failure therapeutic target. J Mol Cell Cardiol 51: 474-478. doi:10.1016/j.yjmcc.2010.10.004. PubMed: 20937286.